Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Lachaine

Showing results (1-10 of 78) with videos related to

Pageof 8
Sort By:
Pharmacoeconomics|September 28, 2006
Therapeutic options for the prevention and treatment of postoperative nausea and vomiting: a pharmacoeconomic reviewJean Lachaine
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Cost-effectiveness of antiemetics use during cancer chemotherapyJean Lachaine, Ralph Crott
The Canadian Journal of Hospital Pharmacy|April 25, 2012
Economic evaluation of dexmedetomidine relative to midazolam for sedation in the intensive care unitJean Lachaine, Catherine Beauchemin
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 11, 2002
Cost-efficacy analysis of ondansetron regimens for control of emesis induced by noncisplatin, moderately emetogenic chemotherapyJean Lachaine, Claudine Laurier
Applied Health Economics and Health Policy|October 25, 2011
An application of a proposed framework for formulary listing in low-income countries: the case of Côte d'IvoireVakaramoko Diaby, Jean Lachaine
Therapeutic Advances in Psychopharmacology|October 23, 2018
Real-world effectiveness of long-acting antipsychotic treatments in a nationwide cohort of 3957 patients with schizophrenia, schizoaffective disorder and other diagnoses in QuebecEmmanuel Stip, Jean Lachaine
BMC Clinical Pharmacology|May 24, 2011
Use, tolerability and compliance of spironolactone in the treatment of heart failureJean Lachaine, Catherine Beauchemin, Elodie Ramos
Maturitas|September 18, 2007
Economic impact of Tibolone compared with Continuous-Combined Hormone Replacement Therapy in the management of climacteric symptoms in postmenopausal womenVakaramoko Diaby, Sylvie Perreault, Jean Lachaine
Journal of Cutaneous Medicine and Surgery|October 22, 2013
Risk of myocardial infarction in canadian patients with psoriasis: a retrospective cohort studyAnnie Levesque, Jean Lachaine, Robert Bissonnette
BMC Psychiatry|January 18, 2016
Is adjunctive pharmacotherapy in attention-deficit/hyperactivity disorder cost-effective in Canada: a cost-effectiveness assessment of guanfacine extended-release as an adjunctive therapy to a long-acting stimulant for the treatment of ADHDJean Lachaine, Vanja Sikirica, Karine Mathurin
Pageof 8

Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
Pharmacoeconomics|September 28, 2006
Therapeutic options for the prevention and treatment of postoperative nausea and vomiting: a pharmacoeconomic reviewJean Lachaine
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Cost-effectiveness of antiemetics use during cancer chemotherapyJean Lachaine, Ralph Crott
The Canadian Journal of Hospital Pharmacy|April 25, 2012
Economic evaluation of dexmedetomidine relative to midazolam for sedation in the intensive care unitJean Lachaine, Catherine Beauchemin
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 11, 2002
Cost-efficacy analysis of ondansetron regimens for control of emesis induced by noncisplatin, moderately emetogenic chemotherapyJean Lachaine, Claudine Laurier
Applied Health Economics and Health Policy|October 25, 2011
An application of a proposed framework for formulary listing in low-income countries: the case of Côte d'IvoireVakaramoko Diaby, Jean Lachaine
Therapeutic Advances in Psychopharmacology|October 23, 2018
Real-world effectiveness of long-acting antipsychotic treatments in a nationwide cohort of 3957 patients with schizophrenia, schizoaffective disorder and other diagnoses in QuebecEmmanuel Stip, Jean Lachaine
BMC Clinical Pharmacology|May 24, 2011
Use, tolerability and compliance of spironolactone in the treatment of heart failureJean Lachaine, Catherine Beauchemin, Elodie Ramos
Maturitas|September 18, 2007
Economic impact of Tibolone compared with Continuous-Combined Hormone Replacement Therapy in the management of climacteric symptoms in postmenopausal womenVakaramoko Diaby, Sylvie Perreault, Jean Lachaine
Journal of Cutaneous Medicine and Surgery|October 22, 2013
Risk of myocardial infarction in canadian patients with psoriasis: a retrospective cohort studyAnnie Levesque, Jean Lachaine, Robert Bissonnette
BMC Psychiatry|January 18, 2016
Is adjunctive pharmacotherapy in attention-deficit/hyperactivity disorder cost-effective in Canada: a cost-effectiveness assessment of guanfacine extended-release as an adjunctive therapy to a long-acting stimulant for the treatment of ADHDJean Lachaine, Vanja Sikirica, Karine Mathurin
Pageof 8